Equivalent price position
No other current listing with the same generic, strength, dosage form and compatible unit basis is available for comparison.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Diatrizoate Meglumine
- Therapeutic area
- Diagnostic agents
- Drug class
- Radiographic contrast media
- ATC
- V08AA
- Strength
- 660 mg
- Dosage form
- Injection
- Pack
- 1's x 20 ml
- Registration no.
- 115799
- Price record verified
- 2026-08-24
- Latest DRAP source check
- 2026-09-27 02:57
Manufacturer
Lab Diagnostic Systems (SMC) Pvt. Ltd.
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →Official price over time
PKR 359.16 to 376.90 (+4.9%) between 1 Jul 2025 and 20 Aug 2026 · 2 official price records · pack 1's x 20 ml
Step chart: a notified price holds until DRAP notifies the next one. Hover or tap a point for its date and change.
Cite this price history
MedInfoBase. Visoate I 660 mg, 1's x 20 ml: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/visoate-i-660-mg-115799-1s-x-20-ml-lab-diagnostic-systems-smc-pvt-ltd/ (accessed 27 September 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 376.90 | 2026-08-20 | 2026-08-24 | DRAP PharmaPrice Index | Current |
| PKR 359.16 | 2025-07-01 | 2026-08-09 | DRAP PharmaPrice Index | Historical |
Other listed brands
Cite this record
Medicine record · DRAP registration 115799Price and registration data on this page were observed on 24 August 2026. Records change over time, so please cite the observation date alongside the access date.
